Clinical Trial Update: Palbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial of palbociclib in combination with chemotherapy for pediatric patients with relapsed or refractory acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Tanja Andrea Gruber | Conditions: Acute Lymphoblastic Leukemia, Pediatric, Relapsed Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED